G. Funk (Vienna, Austria), T. Rochat (Geneve 14, Switzerland)
Severity of lung disease in siblings with α-1-antitrypsin deficiency (AATD)
S. B. Shaker, N. Seersholm, M. Hestad, S. Andersen, L. T. Skovgaard, B. C. Stoel, A. Dirksen (Copenhagen, Denmark; Leiden, Netherlands)
|   |
Characterization of a population of alpha1-antitrypsin deficient (A1ATD) patients
F. Costa, L. Rodrigues, Y. Martins, C. Mendonça (Coimbra, Portugal)
| |
SERPINA1 gene variants in subjects from a general population with reduced alpha1-antitrypsin level
S. Ottaviani, E. Russi, O. Senn, M. Imboden, I. Campo, I. Ferrarotti, R. Scabini, M. Zorzetto, M. Luisetti, N. Probst-Hensch, SAPALDIA Team (Pavia, Italy; Zurich, Switzerland)
| |
Simvastatin does not reduce levels of inflammatory blood markers in patients with stable chronic obstructive pulmonary disease
P. Kaczmarek, K. Sladek, M. Rzeszutko, T. Iwaniec, S. Dziedzina, A. Szczeklik, W. Skucha, A. Undas (Cracow, Proszowice, Poland)
| |
Are more patients on home oxygen followed up, if a respiratory department has the opportunity of doing home visits by a respiratory nurse?
T. Ringbaek, M. Willemann, J. Albaek, A. Hvenegaard (Hvidovre, Copenhagen, Copenhagen, Denmark)
| |
Advanced chronic obstructive pulmonary disease is associated with poor self-rated health
J. Farkas, L. Zaletel-Kragelj, S. Suskovic, M. Flezar, M. Kosnik, M. Lainscak (Ljubljana, Golnik, Slovenia)
| |
A prospective study evaluating oxygen prescription and delivery in a district general hospital (DGH)
A. Collins, A. Janjua, G. Tack, J. Barrie, N. Ikram, M. Babores (Macclesfield, United Kingdom)
| |
Erythropoietin dysregulation in chronic obstructive pulmonary disease
E. Sala, C. Villena, C. Balaguer, A. Rios, B. G. Cosio, A. Noguera, A. Agusti (Mallorca, Spain)
| |
Factors that predict exacerbation severity and recovery measured with the exacerbations of chronic obstructive pulmonary disease (EXACT) tool
T. Wilcox, S. Sethi, N. Kline Leidy (Bethesda, MD, Buffalo, NY, United States Of America)
| |
The heart rate variability in patients with chronic obstructive pulmonary disease
E. Petukhova, Y. Krasnova, A. Dzizinskii (Irkutsk, Russian Federation)
| |
Prevalence of adenomatous colorectal polyp in patients with chronic obstructive pulmonary disease
J. H. Lee, S. Y. Lim, E. M. Chun, Y. J. Ryu, J. H. Chang (Seoul, Democratic People'S Republic Of Korea)
| |
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of chronic obstructive pulmonary disease
D. Stolz, T. Breidthardt, M. Christ-Crain, R. Bingisser, D. Miedinger, J. Leuppi, B. Müller, M. Tamm, C. Müller (Basel, Switzerland)
| |
Management of COPD in general practice in Denmark – can participating in an educational programme improve adherence to guidelines?
C. S. Ulrik, E. F. Hansen, K. Roslind, M. Skov-Jensen, J. Dollerup, G. Hansen, On Behalf of the KVASIMODO II Study Group (Hvidovre, Skive, Ballerup, Denmark)
| |
Differences in symptoms that precede an exacerbation that influence treatment decisions
N. Hanania, A. Anzueto, A. Emmett, G. Crater (Houston, TX, San Antonio, TX, RTP, NC, United States Of America)
| |
Effect of biologic lung volume reduction (BLVR) therapy on BODE at 6 and 12 weeks
V. Pinto-Plata, L. Kenney, C. J. Criner, M. Gottfried, M. M. Dransfield, C. Strange, Y. Refaely, B. Celli (Boston, MA, Philadelphia, PA, Phoenix, AZ, Birmingham, AL, Charleston, SC, United States Of America; Petah Tikva, Israel)
| |
Ambulatory oxygen audit at district general hospital
T. Win, C. Wotton, C. Milton (Stevenage, United Kingdom)
| |
Neu-164, a novel antioxidant and anti-inflammatory compound, reduces cigarette smoke-induced lung inflammation
R. Phipps, T. Thatcher, P. Sime, M. Laudon, E. Pinner (New York, United States Of America; Tel Aviv, Israel)
| |
Characterisation of the pathways in cigarette smoke induced skeletal muscle atrophy and regeneration after cessation in mice
M. Hansen, D. Allan, L. Kosack, H. J. Seow, S. Langenbach, L. Dousha, J. Jones, G. Anderson (Parkville, VIC, Australia)
| |
Concentrations of the hydrogen peroxide and nitrite in exhaled breath condensate as markers of inflammatory lung diseases
E. Anaev, A. Karyakin, T. Anokhina, V. Apyari, A. Borisova, S. Dmitriyenko, A. Chuchalin (Moscow, Russian Federation)
| |